Occipital neuralgia

SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022

Retrieved on: 
Thursday, November 17, 2022
Sutter Health, Doctor of Philosophy, Low back pain, Judgement, Skin, Cervicogenic headache, Head, SPR, 2021 Essex County Council election, NP-hardness, Risk, Pain, Twilight anesthesia, Therapy, Chronic pain, Medtech, Patient, PNS, Database, Physician, Headache, Disability, Erythema, Society, SPRINT, OH, ASRA, Pain management, Occipital neuralgia, Neck, Knee, Quality of life, Shoulder, Infection, Neck pain, Safety, Dentistry

CLEVELAND, Nov. 17, 2022 (GLOBE NEWSWIRE) -- At the 21st Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in Orlando, SPR Therapeutics is highlighting five new data sets demonstrating significant pain relief for a majority of patients resulting from 60-day PNS treatment using the SPRINT PNS System.

Key Points: 
  • CLEVELAND, Nov. 17, 2022 (GLOBE NEWSWIRE) -- At the 21st Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in Orlando, SPR Therapeutics is highlighting five new data sets demonstrating significant pain relief for a majority of patients resulting from 60-day PNS treatment using the SPRINT PNS System.
  • The abstract titled Real-world evidence of significant pain relief following 60-day stimulation of occipital nerves for the treatment of chronic pain features data presented for the first time based on anonymized outcomes of patients who opted in to provide information and were treated for headache pain in the occipital region.
  • The occipital nerves are a common target for interventional management of conditions such as occipital neuralgia, cervicogenic headache, and other head pain indications and SPRINT is the only implantable PNS system that enables on-label stimulation of the occipital nerve for the treatment of chronic pain.
  • SPR Therapeutics is a privately held medical device company, providing patients with a non-opioid, minimally invasive pain treatment option.

Excitement Is Building for the Boston PAINWeekEnd Conference--Pain Management for the Main Street Practitioner

Retrieved on: 
Tuesday, March 1, 2022
Harvard Medical School, Partnership, Chronic pain, Cabot Street Cinema Theatre, CBD, Clinical, PWE, Accreditation, CME, FAHS, Diabetes, Practitioner, Education, Mass, ACCME, Pain management, Nursing, Medicine, FAAN, Pharmacist, Practice management, National Conference, CTI Education Group, Ultimate Medical Academy, Dentist, Peripheral neuropathy, Occipital neuralgia, Cervicogenic headache, Update, Conference, Secrecy, Patient, Diagnosis, Pharmaceutical industry, Medical device, Global, Pain, MD

On March 12, PWE comes to the Sheraton Boston Needham, 100 Cabot Street in Needham, and will be comprised of certified and noncertified activities that address a range of clinical and practice management areas of interest.

Key Points: 
  • On March 12, PWE comes to the Sheraton Boston Needham, 100 Cabot Street in Needham, and will be comprised of certified and noncertified activities that address a range of clinical and practice management areas of interest.
  • My course, and the others at PAINWeekEnd Boston, will help attendees return to work better informed and better able to tackle pain management issues."
  • PAINWeekEnd Boston is an opportunity to attend a live didactic program presented by nationally recognized experts in a convenient local location."
  • For more information about this or other regional conferences, and to register for $129, go to the PAINWeekEnd website.